Clinical Trial Information Published

The clinical trial for “AOC 1020” (commonly known as del-brax), an FSHD treatment currently under development by Avidity Biosciences, has been officially approved for conduct in Japan.

For detailed clinical trial information, please click here.

https://mdcst.jp/ct/ctinfo/?fbclid=IwdGRleAOc0iRleHRuA2FlbQIxMQBzcnRjBmFwcF9pZAo2NjI4NTY4Mzc5AAEecg4gW0vI4jk_ZzmA7oLreM -LMVA1vcHnNB2OvXaiu7F9SDfsNO_YCXRV234_aem_CBx9w1vXxRo3TUtHsx6uQQ#fshd